AwesomeCapital
Search This Blog
Wednesday, September 4, 2019
Ovid Therapeutics started at Outperform by RBC
Target $12
https://www.benzinga.com/stock/OVID/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.